Laboratory of Biomedical Science, Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY 11030, USA.
Protein Cell. 2013 Mar;4(3):163-7. doi: 10.1007/s13238-012-2118-2. Epub 2013 Mar 13.
High mobility group box 1 (HMGB1) is an evolutionarily conserved non-histone chromatin-binding protein. During infection or injury, activated immune cells and damaged cells release HMGB1 into the extracellular space, where HMGB1 functions as a proinflammatory mediator and contributes importantly to the pathogenesis of inflammatory diseases. Recent studies reveal that inflammasomes, intracellular protein complexes, critically regulate HMGB1 release from activated immune cells in response to a variety of exogenous and endogenous danger signals. Double stranded RNA dependent kinase (PKR), an intracellular danger-sensing molecule, physically interacts with inflammasome components and is important for inflammasome activation and HMGB1 release. Together, these studies not only unravel novel mechanisms of HMGB1 release during inflammation, but also provide potential therapeutic targets to treat HMGB1-related inflammatory diseases.
高迁移率族蛋白 B1(HMGB1)是一种进化上保守的非组蛋白染色质结合蛋白。在感染或损伤期间,激活的免疫细胞和受损细胞将 HMGB1 释放到细胞外空间,HMGB1 在那里作为促炎介质发挥作用,并对炎症性疾病的发病机制有重要贡献。最近的研究表明,细胞内蛋白复合物——炎性体,在各种外源性和内源性危险信号刺激下,对激活的免疫细胞中 HMGB1 的释放进行严格调控。双链 RNA 依赖的蛋白激酶(PKR)是一种细胞内危险感应分子,与炎性体成分相互作用,对于炎性体的激活和 HMGB1 的释放非常重要。综上所述,这些研究不仅揭示了炎症过程中 HMGB1 释放的新机制,而且为治疗与 HMGB1 相关的炎症性疾病提供了潜在的治疗靶点。